Brawn Biotech Ltd vs Norris Medicines Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 12, 2026

Key Highlights

The Latest Trading Price of Brawn Biotech Ltd is ₹ 20.5 as of 12 May 15:30 . The P/E Ratio of Brawn Biotech Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Norris Medicines Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Brawn Biotech Ltd changed from ₹ 6.63 crore on March 2021 to ₹ 4.88 crore on March 2025 . This represents a CAGR of -5.95% over 5 yearsThe Market Cap of Norris Medicines Ltd changed from ₹ 6.5 crore on March 2021 to ₹ 16.78 crore on March 2025 . This represents a CAGR of 20.89% over 5 years The revenue of Brawn Biotech Ltd for the Dec '25 is ₹ 4.4 crore as compare to the Sep '25 revenue of ₹ 4.98 crore. This represent the decline of -11.65% The revenue of Norris Medicines Ltd for the Dec '25 is ₹ 3.27 crore as compare to the Sep '25 revenue of ₹ 2 crore. This represent the growth of 63.5% The ebitda of Brawn Biotech Ltd for the Dec '25 is ₹ 0.08 crore as compare to the Sep '25 ebitda of ₹ 0.1 crore. This represent the decline of -20% The ebitda of Norris Medicines Ltd for the Dec '25 is ₹ 0.95 crore as compare to the Sep '25 ebitda of ₹ -0.49 crore. This represent the decline of -293% The net profit of Brawn Biotech Ltd changed from ₹ -0.53 crore to ₹ 0.05 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Norris Medicines Ltd changed from ₹ -0.37 crore to ₹ 0.7 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of Brawn Biotech Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Norris Medicines Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Brawn Biotech Ltd

Brawn Biotech Limited was originally incorporated in the name of Brawn Pharmaceuticals Limited in November, 1985.
Thereafter, the name of the Company was changed from Brawn Pharmaceuticals Limited to Brawn Biotech Limited in November, 2010.
Brawn, with its inception barely 38 years back has today evolved into a fully integrated, healthcare group, marking its presence in India and across the globe. The Company possess product registration with major health and govt. institutions throughout India and worldwide.
Headed and represented by a team of skilled industry experts with impressive educational backgrounds and broad experience, the Company has spread its wings in expansion in the domestic as well as in the international markets beyond the existing horizon to stand among the leading Indian HealthCare products distribution Companies.

About Norris Medicines Ltd

Norris Medicines Limited was established in September, 1990 as a small scale unit at GIDC Estate, Ankleshwar to manufacture non sterile dosage e.g. tablets, capsules, Liquid Orals, Copical ointments.
The Company was subsequently converted into Public Limited Company on March 7, 1992.
The unit expanded to manufacture Sterile dosage in form of Ampoules & Vials. The Company got into the business in the year 1990.
Commercial production of the formulation unit commenced in Nov.'91.
The production unit expanded to manufacture Sterile dosage in form of Ampoules & Vials.

FAQs for the comparison of Brawn Biotech Ltd and Norris Medicines Ltd

Which company has a larger market capitalization, Brawn Biotech Ltd or Norris Medicines Ltd?

Market cap of Brawn Biotech Ltd is 5 Cr while Market cap of Norris Medicines Ltd is 14 Cr

What are the key factors driving the stock performance of Brawn Biotech Ltd and Norris Medicines Ltd?

The stock performance of Brawn Biotech Ltd and Norris Medicines Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Brawn Biotech Ltd and Norris Medicines Ltd?

As of May 12, 2026, the Brawn Biotech Ltd stock price is INR ₹19.0. On the other hand, Norris Medicines Ltd stock price is INR ₹14.95.

How do dividend payouts of Brawn Biotech Ltd and Norris Medicines Ltd compare?

To compare the dividend payouts of Brawn Biotech Ltd and Norris Medicines Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.